Summary
The Credit Suisse 2018 Washington Perspectives Conference will discuss the predictability of merger outcomes in today's M&A environment.
For more information, please visit the event website.
Related Content
- InsightDecember 27, 2023
Antitrust & Competition Technology Quarterly Update Q3 2023
- InsightOctober 23, 2023
Antitrust & Competition Life Sciences Quarterly Update Q3 2023
- InsightAugust 24, 2023
Antitrust & Competition Technology Quarterly Update Q2 2023
- InsightAugust 11, 2023
Antitrust & Competition Life Sciences Quarterly Update Q2 2023
- InsightAugust 11, 2023
Antitrust & Competition Healthcare Quarterly Update Q2 2023
- InsightJune 14, 2023
Antitrust & Competition Technology Quarterly Update Q1 2023
- InsightMay 22, 2023
Antitrust & Competition Healthcare Quarterly Update Q1 2023
- InsightMay 22, 2023
Antitrust & Competition Life Sciences Quarterly Update Q1 2023
- Speaking EngagementsMay 3, 2024 | 9:05 AM - 9:45 AM PT
Informa Connect Antitrust West Coast 2024 Conference
- WebinarJanuary 16, 2024
Goodwin CLE Days 2024
- Press ReleaseJanuary 11, 2024
Renesas to Acquire Transphorm in $339 Million Transaction
- Press ReleaseJanuary 10, 2024
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Press ReleaseJanuary 8, 2024
Harpoon Therapeutics To Be Acquired by Merck for $680 Million
- Press Release5 January 2024
Stirling Square, TA and Macquarie Capital, through Giant BidCo, announce a recommended public cash offer of SEK 46 to the shareholders of Byggfakta
- Awards and RankingsDecember 20, 2023
Goodwin Named an Elite Firm for Antitrust Law by GCR 100 2024
- In the PressNovember 30, 2023
Cigna-Humana Deal Would Face Intense Anti-Trust Scrutiny (Axios)